Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05492682 |
Title | START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Valo Therapeutics Oy |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | DEU |